Apollo VCT portfolio company story: Perfect Ward

A digital quality inspection platform designed to support the health and social sectors.

Perfect Ward is used across a rapidly expanding base of hospitals, care homes and other health and social care organisations in the UK and internationally. The software helps organisations like hospitals to continually drive improvements in patient care, through making quality inspections digital.

Perfect Ward combines the clinical knowledge of frontline staff with an intuitive digital platform. This allows hospitals and care providers to better track, monitor and document their processes, enabling them to make better decisions and ensuring compliance with industry regulations.

We think it’s the perfect time to be investing in this space, with COVID-19 accelerating the focus that healthcare providers have to place on clinical inspections. The combination of clinical knowledge and a digital platform has enabled Perfect Ward to deliver best in class inspections across clinical environments at a time when it is needed the most.

There was a real opportunity to add value to the management team as they continue their journey to become a global software business. In preparation for that, Perfect Ward has taken the forward-thinking step of developing new modules within its app and further bolstering their web platform to make their product even more scalable.

First investment date

November 2020

– Richard Court, Fund Manager, Octopus Apollo VCT

Richard Court - Head of Development Capital - Octopus Investments

Key risks to remember

Please remember that the value of an investment in Octopus Apollo VCT, and any income from it, can fall as well as rise. Investors may not get back the full amount they invest.

Tax treatment depends on individual circumstances and may change in the future. Tax reliefs depend on the VCT maintaining its qualifying status.

VCT shares could fall or rise in value more than shares listed on the main market of the London Stock Exchange. They may also be harder to sell.

Investors should only subscribe for shares on the basis of information contained in the prospectus and Key Information Document (KID), available on the Apollo VCT product page.

More companies we’ve backed